MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字HJ20180089

July 4, 2023

H20180089

Drug Information

盐酸莫西沙星滴眼液

维莫思

眼用制剂

按C₂₁H₂₄FN₃O₄计,5ml:25mg(0.5%,w/v)

化学药品

July 4, 2023

July 3, 2028

Company Information

Applicant Company

1 Health Plz, East Hanover, NJ 07936 United States of America

Manufacturing Company

6201 South Freeway, Fort Worth, TX 76134 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath